VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study

Thierry Berghmans, Jean-Jacques Lafitte, Arnaud Scherpereel, Lieveke Ameye, Marianne Paesmans, Anne-Pascale Meert, Benoit Colinet, Christian Tulippe, Luc Willems, Nathalie Leclercq, Jean-Paul Sculier, for the European Lung Cancer Working Party
ERJ Open Research 2015 1: 00029-2015; DOI: 10.1183/23120541.00029-2015

Article Information

vol. 1 no. 2
DOI 
https://doi.org/10.1183/23120541.00029-2015
PubMed 
27730152
Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received May 22, 2015
  • Accepted August 9, 2015
  • Published online October 19, 2015.
Copyright & Usage 
Copyright ©ERS 2015 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Thierry Berghmans1⇑,
  2. Jean-Jacques Lafitte2,
  3. Arnaud Scherpereel2,
  4. Lieveke Ameye3,
  5. Marianne Paesmans3,
  6. Anne-Pascale Meert1,
  7. Benoit Colinet4,
  8. Christian Tulippe5,
  9. Luc Willems6,
  10. Nathalie Leclercq1,
  11. Jean-Paul Sculier1,
  12. for the European Lung Cancer Working Party
  1. 1Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), Brussels, Belgium
  2. 2Department of Pulmonary and Thoracic Oncology, CHRU de Lille and University of Lille II, France
  3. 3Data Centre, Institut Jules Bordet, Centre des Tumeurs de l'ULB, Brussels, Belgium
  4. 4Department of Pneumology, Grand Hôpital de Charleroi, Gilly, Belgium
  5. 5Department of Pneumology, CH Mouscron, Mouscron, Belgium
  6. 6Gembloux Agro-Bio Tech and Interdisciplinary Cluster for Applied Genoproteomics (GIGA), University of Liège, Gembloux, Belgium
  1. Thierry Berghmans, Institut Jules Bordet, Rue Héger-Bordet 1, 1000 Bruxelles, Belgium. E-mail: thierry.berghmans{at}bordet.be
View Full Text

Article usage

Article usage: October 2015 to April 2022

AbstractFullPdf
Oct 201583224
Nov 20159608
Dec 201556920
Jan 201674135
Feb 201622221
Mar 201684134
Apr 2016124019
May 2016103314
Jun 201641915
Jul 201632432
Aug 201642928
Sep 201622821
Oct 2016247633
Nov 201625478
Dec 20160222
Jan 20172184
Feb 20171255
Mar 20173453
Apr 20170247
May 20171337
Jun 201712611
Jul 20173244
Aug 20171293
Sep 20172808
Oct 20170367
Nov 20170365
Dec 20170418
Jan 20180213
Feb 20180174
Mar 201801938
Apr 201801266
May 201801126
Jun 201801905
Jul 20181831
Aug 201801353
Sep 201801367
Oct 201822592
Nov 201823116
Dec 201802943
Jan 201932176
Feb 201931864
Mar 20191606
Apr 20190113
May 2019136
Jun 20191146
Jul 20190115
Aug 20190210
Sep 2019036
Oct 20192186
Nov 20193228
Dec 20191123
Jan 20200111
Feb 2020042
Mar 2020021
Apr 20200819
May 2020197
Jun 20202913
Jul 20201129
Aug 2020156
Sep 20201114
Oct 20202254
Nov 20200109
Dec 20201114
Jan 20210812
Feb 2021031
Mar 2021072
Apr 20210810
May 20211125
Jun 20210236
Jul 202111013
Aug 2021089
Sep 2021294
Oct 20211515
Nov 202101516
Dec 20210132
Jan 2022184
Feb 2022192
Mar 20220179
Apr 2022082

Altmetrics

Back to top
Email
Print
Citation Tools
VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
Thierry Berghmans, Jean-Jacques Lafitte, Arnaud Scherpereel, Lieveke Ameye, Marianne Paesmans, Anne-Pascale Meert, Benoit Colinet, Christian Tulippe, Luc Willems, Nathalie Leclercq, Jean-Paul Sculier, for the European Lung Cancer Working Party
ERJ Open Research Oct 2015, 1 (2) 00029-2015; DOI: 10.1183/23120541.00029-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects